UA93135C2 - КРИСТАЛІЧНА ФОРМА ГЕМІГІДРАТУ 1-(β-D-ГЛЮКОПІРАНОЗИЛ)-4-МЕТИЛ-3-[5-(4-ФТОРФЕНІЛ)-2-ТІЕНІЛМЕТИЛ]БЕНЗОЛУ - Google Patents
КРИСТАЛІЧНА ФОРМА ГЕМІГІДРАТУ 1-(β-D-ГЛЮКОПІРАНОЗИЛ)-4-МЕТИЛ-3-[5-(4-ФТОРФЕНІЛ)-2-ТІЕНІЛМЕТИЛ]БЕНЗОЛУInfo
- Publication number
- UA93135C2 UA93135C2 UAA200906994A UAA200906994A UA93135C2 UA 93135 C2 UA93135 C2 UA 93135C2 UA A200906994 A UAA200906994 A UA A200906994A UA A200906994 A UAA200906994 A UA A200906994A UA 93135 C2 UA93135 C2 UA 93135C2
- Authority
- UA
- Ukraine
- Prior art keywords
- thienylmethyl
- glucopyranosyl
- fluorophenyl
- methyl
- crystalline form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/04—Carbocyclic radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86842606P | 2006-12-04 | 2006-12-04 | |
JP2006327019 | 2006-12-04 | ||
PCT/JP2007/073729 WO2008069327A1 (en) | 2006-12-04 | 2007-12-03 | CRYSTALLINE FORM OF 1- (β-D-GLUCOPYRANOSYL) -4 -METHYL- 3- [5- (4 -FLUOROPHENYL) -2-THIENYLMETHYL] BENZENE HEMIHYDRATE |
Publications (1)
Publication Number | Publication Date |
---|---|
UA93135C2 true UA93135C2 (uk) | 2011-01-10 |
Family
ID=50486662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200906994A UA93135C2 (uk) | 2006-12-04 | 2007-12-03 | КРИСТАЛІЧНА ФОРМА ГЕМІГІДРАТУ 1-(β-D-ГЛЮКОПІРАНОЗИЛ)-4-МЕТИЛ-3-[5-(4-ФТОРФЕНІЛ)-2-ТІЕНІЛМЕТИЛ]БЕНЗОЛУ |
Country Status (3)
Country | Link |
---|---|
HR (1) | HRP20140254T4 (hr) |
NI (1) | NI200900113A (hr) |
UA (1) | UA93135C2 (hr) |
-
2007
- 2007-12-03 UA UAA200906994A patent/UA93135C2/uk unknown
-
2009
- 2009-06-04 NI NI200900113A patent/NI200900113A/es unknown
-
2014
- 2014-03-18 HR HRP20140254TT patent/HRP20140254T4/hr unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20140254T4 (hr) | 2021-10-29 |
NI200900113A (es) | 2010-11-29 |
HRP20140254T1 (en) | 2014-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY153702A (en) | Crystalline form of 1-(b-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate | |
EA200802119A1 (ru) | Новая кристаллическая форма vi агомелатина, способ его получения и фармацевтические композиции, которые ее содержат | |
RS51954B (en) | CRYSTAL MODIFICATIONS OF PYRACLOSTROBIN | |
EA200601271A1 (ru) | Новая кристаллическая форма iv агомелатина, способ её получения и фармацевтические композиции, которые её содержат | |
MY142108A (en) | CRYSTALLINE FORM OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS | |
IL204145A (en) | Processes for the preparation of sglt inhibitors, crystalline forms of 1– (d – β ––– glucopyranosyl) –4 – chloro – 3– [5– (6-fluoro-3-pyridyl) –2-thienylmethyl] benzene, pharmaceutical preparations containing them and uses In them | |
EA200601274A1 (ru) | Новая кристаллическая форма iii агомелатина, способ её получения и фармацевтические композиции, которые её содержат | |
NZ591027A (en) | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives | |
PL2107913T3 (pl) | Zastosowania tiolowanych polisacharydów do augmentacji tkanek | |
EP2032715A4 (en) | METHODS AND MATERIALS FOR THE PREPARATION OF SIMVASTATIN AND ITS COMPOUNDS | |
CU23774A3 (es) | Inhibición de arni de expresión de alfa-enac | |
TW200731999A (en) | Taste masking of essential oils using a hydrocolloid | |
MX2007000224A (es) | Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos. | |
HRP20110641T1 (hr) | Kristalna modifikacija fipronila | |
RS53057B (en) | NEW CRYSTAL FORM 3- (difluoromethyl) -1-methyl-N- (3`, 4`, 5`-trifluoro [1,1`-biphenyl] -2-yl) -1H-pyrazole-4-carboxamide | |
MX2007010143A (es) | Formas cristalinas de intermedio de linezolid. | |
MX2009004947A (es) | Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6). | |
WO2008083130A3 (en) | Amorphous and crystalline form a of carvedilol phosphate | |
UA93135C2 (uk) | КРИСТАЛІЧНА ФОРМА ГЕМІГІДРАТУ 1-(β-D-ГЛЮКОПІРАНОЗИЛ)-4-МЕТИЛ-3-[5-(4-ФТОРФЕНІЛ)-2-ТІЕНІЛМЕТИЛ]БЕНЗОЛУ | |
WO2008098143A3 (en) | Antimicrobial compounds and methods of use | |
EA200900936A1 (ru) | Аморфные и кристаллические формы ривастигмина гидротартрата | |
JO3523B1 (ar) | صورة متبلرة من نصف هيدرات 1(b-d- جلوكو بيرانوسيل)-4-ميثيل-3-[ 5-(4-قلورو فينيل) -2-ثنيينيل ميثيل]بترين | |
CY1114969T1 (el) | ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΗΜΙΕΝΥΔΡΟΥ 1- (β-D-ΓΛΥΚΟΠΥΡΑΝΟΖΥΛΟ) -4 -ΜΕΘΥΛΟ- 3- [5- (4-ΦΘΟΡΟΦΑΙΝΥΛΟ)-2- ΘΕΙΕΝΥΛΟΜΕΘΥΛΟ]ΒΕΝΖΟΛΙΟΥ | |
WO2008131859A3 (de) | Verwendimg cyclisch substituierter furopyrimidin-derivate zur behandlung der pulmonalen arteriellen hypertonie | |
TW200640854A (en) | Methods of making pravastatin sodium |